Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00578994 · ClinicalTrials.gov registry record
A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System
A clinical trial of Osteoarthritis and Avascular Necrosis, sponsored by Biomet Orthopedics.
- Completed
- Registry status
- 388
- Enrollment target
- 6
- Study locations
NCT00578994 is a study of Osteoarthritis and Avascular Necrosis that has completed, run by Biomet Orthopedics. The registered enrollment target is 388 participants, below the 815-participant average among 135 other Osteoarthritis trials with a reported enrollment target (52% lower). The trial reports 6 study locations across 5 states.
The verdict
NCT00578994, a study of Osteoarthritis and Avascular Necrosis, has completed, sponsored by Biomet Orthopedics.
- COMPLETED
- Registry status
- 388 participants
- Enrollment target
- 6
- Study locations
Study Summary
The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in the United States.
Conditions Studied
Interventions
- DEVICE Oxford® Meniscal Unicompartmental Knee System
Study Locations (6)
Texas
- Texas Orthopedic Specialist - Bedford
- Texas Center for Joint Replacement - Plano
Illinois
- Barrington Orthopedic Specialissts - Schaumburg
Ohio
- Joint Implant Surgeons - New Albany
Tennessee
- Mid-South Orthopedic Associates - Cordova
Virginia
- Advanced Orthopaedic Centers - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 388 participants |
| Start Date | 2006-03 |
| Est. Completion | 2021-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00578994
The ClinicalTrials.gov registry entry for NCT00578994 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 388 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 815-participant average among 135 other Osteoarthritis trials with a reported enrollment target (52% lower). The listed sponsor is Biomet Orthopedics, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Oxford® Meniscal Unicompartmental Knee System is the first listed.
NCT00578994 reports 6 study locations spanning 5 distinct geographic areas - top geographies include Texas, Illinois, Ohio.
Frequently Asked Questions
What is clinical trial NCT00578994 about?
NCT00578994 is a clinical study titled "A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System". The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in the United States.
What is the current status of trial NCT00578994?
This trial is currently completed. The enrollment target is 388 participants. The study started on 2006-03. Estimated completion is 2021-03-31.
What conditions does trial NCT00578994 study?
This clinical trial studies the following conditions: Osteoarthritis, Avascular Necrosis.
What interventions are being tested in trial NCT00578994?
The interventions under investigation include: Oxford® Meniscal Unicompartmental Knee System (DEVICE).
Who is sponsoring clinical trial NCT00578994?
This trial is sponsored by Biomet Orthopedics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00578994 being conducted?
This trial has 6 study locations across Illinois, Ohio, Tennessee, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Safety & Effectiveness of Autologous Regenerative Cell Therapy on Pain & Inflammation of Osteoarthritis of the Knee
RECRUITING · Phase 2
-
A Prospective, Post-Market, Clinical Follow-up Study of the Incompass™ Total Ankle System
RECRUITING
-
Reliability of Pupil Response to Acute Pain
RECRUITING
-
EMPHASYS Cup Positioning in THA With Non-Invasive Navigation (Velys Hip Navigation (VHN))
RECRUITING · NA
-
Ketorolac in Upper Extremity Tendinopathy and Arthropathy
RECRUITING · Phase 4
-
The PROACTIVE Study for Black Elders
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.